Skip to main content

Allarity Therapeutics, Inc.

ALLR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001860657

No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Allarity Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
4
−5 vs. Q2 2024
Shares held
21.9K
−488.5K (−95.7%) vs. Q2 2024
Total value
$46.2K
−$61.6K (−57.2%) vs. Q2 2024
New holders
1
0 more added
Sold out
6
3 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 4 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 3 institutionsQ1 2022: 10 institutionsQ2 2022: 10 institutionsQ3 2022: 10 institutionsQ4 2022: 10 institutionsQ1 2023: 6 institutionsQ2 2023: 4 institutionsQ3 2023: 7 institutionsQ4 2023: 4 institutionsQ1 2024: 4 institutionsQ2 2024: 9 institutionsQ3 2024: 4 institutionsQ4 2024: 6 institutionsQ1 2025: 9 institutionsQ2 2025: 10 institutionsQ3 2025: 11 institutionsQ4 2025: 16 institutionsQ1 2026: 14 institutionsQ2 2026: 20 institutions
Value heldQ3 2024: $46.2K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $270.0KQ1 2022: $694.0KQ2 2022: $304.0KQ3 2022: $181.0KQ4 2022: $42.0KQ1 2023: $4.05KQ2 2023: $33.3KQ3 2023: $515.6KQ4 2023: $31.8KQ1 2024: $11.7KQ2 2024: $107.8KQ3 2024: $46.2KQ4 2024: $122.3KQ1 2025: $86.5KQ2 2025: $197.0KQ3 2025: $1.63MQ4 2025: $1.40MQ1 2026: $1.04MQ2 2026: $1.65M
Institutions holding ALLR and their total value by quarter
QuarterHoldersValue
Q2 202620$1.65M
Q1 202614$1.04M
Q4 202516$1.40M
Q3 202511$1.63M
Q2 202510$197.0K
Q1 20259$86.5K
Q4 20246$122.3K
Q3 20244$46.2K
Q2 20249$107.8K
Q1 20244$11.7K
Q4 20234$31.8K
Q3 20237$515.6K
Q2 20234$33.3K
Q1 20236$4.05K
Q4 202210$42.0K
Q3 202210$181.0K
Q2 202210$304.0K
Q1 202210$694.0K
Q4 20213$270.0K
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding ALLR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG18,452$38.9K0.00%−22,760−55.2%Reduced
Tower Research Capital LLC (TRC)3,403$7.18K0.00%−8,761−72.0%Reduced
Bank of America Corp11$230.00%−134−92.4%Reduced
Danske Bank A/S8$170.00%+8New
Virtu Financial LLC0$00.00%−265,338−100.0%Sold out
Geode Capital Management, LLC0$00.00%−102,328−100.0%Sold out
Jump Financial, LLC0$00.00%−38,795−100.0%Sold out
HRT Financial LP0$00.00%−34,691−100.0%Sold out
Jane Street Group, LLC0$00.00%−15,667−100.0%Sold out
Headlands Technologies LLC0$00.00%−20−100.0%Sold out